This platform was created after a personal diagnosis revealed how fragmented and difficult it is to find clear, reliable information about clinical trials and emerging cancer treatments. Breakthroughs are happening around the world, but the information is scattered across databases, journals, and institutions—often written in language that is difficult for patients and families to navigate.
We believe people facing cancer deserve something better.
So we built Zyntha.
Zyntha searches global medical databases, clinical trials, and cutting-edge research to identify the latest breakthroughs for each cancer type. We translate complex science into clear, practical insights that help patients and families understand their options.
Zyntha handles the research—so you can focus on the decisions that matter most.
We monitor over 2,500 global medical sources 24/7, analyze new studies as they emerge, and organize everything by clinical significance.
We continuously scan ClinicalTrials.gov, PubMed, FDA, and 2,500+ medical sources for new research across 9 tumor types.
Every study is classified by tumor type, scored for relevance, and enriched with molecular markers and treatment data.
Browse specialized portals, explore active clinical trials, or read curated intelligence — all in plain language.
Every study, trial, and article is summarized so that patients and families can actually understand it — no medical degree required.
We run 24/7, scanning 120+ sources. New trials and publications appear here within hours — not weeks or months.
Specialized portals for 9 different CNS tumor types. Every feature — from molecular markers to subtype filters — is tailored to each condition.
All content is sourced from peer-reviewed medical journals, verified trial registries, and top cancer research centers worldwide.